Myasthenia gravis associated with ipilimumab and nivolumab in the treatment of small cell lung cancer

Muscle Nerve. 2015 Aug;52(2):307-8. doi: 10.1002/mus.24648. Epub 2015 May 14.

Authors

Aaron I Loochtan¹, Myles S Nickolich², Lisa D Hobson-Webb¹

Affiliations

¹ Department of Neurology, Duke University Medical Center, Durham, North Carolina, USA.
² Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA.

PMID: 25759003
DOI: 10.1002/mus.24648

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Aged
Antibodies, Monoclonal / adverse effects*
Humans
Ipilimumab
Lung Neoplasms / diagnosis
Lung Neoplasms / drug therapy*
Male
Myasthenia Gravis / chemically induced*
Myasthenia Gravis / diagnosis*
Nivolumab
Small Cell Lung Carcinoma / diagnosis
Small Cell Lung Carcinoma / drug therapy*

Substances

Antibodies, Monoclonal
Ipilimumab
Nivolumab